[PDF] Top 20 Emerging Therapeutic Options in the Treatment of Moderate to Severe Plaque Psoriasis

... – Psoriasis is a very common, chronic and recurrent, inflammatory systemic disease, which affects the skin and/or ...but plaque psoriasis is the most common and around 20% of ... See full document

... known to be effective and safe in childhood and adolescent psoriasis, but little has been published on the combined use of psoralen with ultraviolet-A ...radiation. The aim ... See full document

... effective to provide remission and control of symptoms in moderate to severe ...Among the main side effects related to them, infections, ... See full document

... compared the efficacy and safety of adalimumab, MTX and placebo in moderate-to-severe ...responses to the same doses of MTX, related to ... See full document

... all the children had a good initial response. Therefore, we found that low to moderate doses can be effective in clearing ...psoriasis. In fact, with these doses, we observed a ... See full document

... enrolled in the previously reported phase III clinical trials were individuals with ≥18 years of agewith moderate- to-severe plaque psoriasis for at least 6 months ... See full document

... one of the most common skin diseases affecting 10%-20% of children and 1%-3% of adults, and it is a significant cause of morbidity, quality-of-life impairment and health-care ... See full document

... – Psoriasis is an inflammatory dermatosis, affecting approximately 2% of the population, with predomi- nantly skin and joint involvement but also associated with considerable ...20% to 30% ... See full document

... Considering the treatment response according to the patients’ weight ...tendency to inferior clinical re- sponse was observed in patients weighting 90 - 100 ...under the ... See full document

... 2% of the population, with predominantly skin and joint involvement but also associated with considerable ...20% to 30% of patients have moderate to severe disease uncon- ... See full document

... – Psoriasis is a chronic inflammatory disorder, multisystem and immunologically ...third of adults refer the age of onset before 16, representing about 4% of all dermatoses seen ... See full document

... with moderate to severe psoriasis and compared risankizumab with ...randomized to receive risankizumab subcuta- neously (18-mg single dose or 90- or 180-mg doses at weeks 0, 4, and 16) ... See full document

... patients in each group did not complete the proposed two months of ...treatment. In the group using lacquer as vehicle, two patients reported severe pruri- tus associated ... See full document

... for the treatment of psoriasis in Germany, since ...used in moderate to severe plaque-type ...for the treatment of ... See full document

... History of Asthma: Outcomes and Treatment Regimens (TENOR) study was a multicenter, cohort study involving pediatric and adult patients classified as having difficult-to-treat asthma (DTA), with an ... See full document

... reports of HBV reactivation after immune suppression. It is known that the HBV integrates with the host genome and can remain indefinitely in the nucleus of hepatocytes in ... See full document

... limitations. The goal of posterior surgery is stabilization in order to prevent further progression rather than correction of the ...limited to 28% in those fused ... See full document

... All the patients were offered the same treatment, as guided by what is the standard care at the ...according to a protective ventilation paradigm and was not associated with ... See full document

... out to identify re- levant studies published between 2005 (when the first trial about the first anti-TNF drug, infliximab, was pu- blished) and October ...2013. The electronic search was ... See full document

... study of 263 children treated at this center between August of 2008 to August of 2011, aged 1 to 6 years, diagnosed with moderate (z-score of height-for-age [HAZ] < -2) ... See full document